Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weight-based vs Fixed Corticosteroid Dosage in Crohn's Disease
NCT02392286Phase 4Terminated
- Sponsor
- Yale University
- Start
- Mar 2015
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisone in Crohn's disease, sponsored by Yale University. Started Mar 2015; status: terminated.
02
Drugs
prednisone
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02392286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02392286.